Journals in Diabetes

Atherosclerosis

ISSN: 0021-9150
5 Year impact factor: 5.3
Impact factor: 4.9

Cardiovascular disease (CVD) causes one third of all deaths worldwide and is a major threat to global health. Atherosclerosis aims to provide a comprehensive platform for researchers, clinicians and healthcare professionals to share the latest findings and advances in the field of atherosclerosis. Atherosclerosis covers a wide range of topics, including:Pathophysiology and Mechanisms: We explore the intricate cellular and molecular processes involved in atherogenesis, from the initial formation of fatty streaks to the development of complex plaques. We also welcome studies on cardiac biology and disease.Risk Factors: We consider manuscripts that examine both traditional and emerging risk factors for atherosclerosis, such as dyslipidaemia, hypertension, diabetes mellitus, thrombosis and genetic predisposition.Prevention of CVD: Since prevention will become a major focus in the future (see e.g. the European Cardiovascular Health Plan), an important focus will be on preventive strategies, including lifestyle modifications and pharmacological interventions.Diagnostics Techniques: We features articles on cutting-edge diagnostic techniques, ranging from invasive procedures such as selective coronary arteriography to non-invasive techniques such as blood biomarkers.Treatment Approaches: Atherosclerosis covers the latest developments in the treatment of atherosclerosis, including lipid-lowering therapies, anti-inflammatory treatments and novel targeted approaches aimed at modifying disease progression and improving clinical outcomes.Translational Research: We bridges the gap between basic science and clinical practice by highlighting translational studies that bring laboratory findings closer to practical applications in patient care.By fostering collaboration and knowledge exchange between researchers and clinicians, Atherosclerosis aims to accelerate progress in the understanding, prevention and treatment of atherosclerosis, ultimately improving the lives of the millions of people affected by this pervasive disease.

Biochimica et Biophysica Acta: Molecular Basis of Disease

ISSN: 0925-4439
5 Year impact factor: 5.5
Impact factor: 4.2

BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease.Manuscripts should emphasize the underlying molecular mechanisms of human disease pathways and provide significant advances to the understanding and/or treatment of these disorders.Studies in model organisms or systems are strongly recommended in order to validate mechanistic insights. Topics of interest include, but are not limited toAgingCancerCardiovascular diseasesCell death–related diseasesGenetic diseasesGenetic and epigenetic regulation in diseasesImmunological diseasesInflammatory diseasesMetabolic diseasesMitochondrial diseasesMuscular diseasesNeurological diseasesThe non-preferred topics for BBADIS includeNon-coding RNAsResearch on non-coding RNAs (microRNAs, lncRNAs, circRNAs, etc.) will be considered only if it provides significantly novel insights into disease mechanisms.Single Cell Line StudiesStudies involving single cell lines will be considered only if they present significantly novel findings.Computational (in Silico) StudiesPurely computational works (e.g., Mendelian randomization, molecular docking, molecular dynamics) will generally be declined unless they provide novel insights into disease mechanisms.Disease BiomarkersResearch on disease biomarkers will be considered only if it relates to the explanation of disease mechanisms.Descriptive or Correlative StudiesDescriptive or correlative studies (e.g., up/down regulation of gene products, -omics studies without follow-up experiments) will be declined unless they provide mechanistic insights.Natural Products and Traditional MedicineWork on natural products, extracts, and traditional medicine will be considered only if single biochemical components are characterized and tested.Clinical Studies and Case ReportsClinical studies or case reports without mechanistic insights are outside the scope of the journal.Hypothesis ArticlesSubmissions based solely on hypotheses will not be considered.Comparative Genomics StudiesComparative genomics studies (e.g., GWAS) will only be considered if they provide specific insights into the structural and/or functional properties of individual genes.Incremental WorkResearch that offers incremental advancements without significant novelty or impact will generally be declined.

Biochimica et Biophysica Acta: Molecular and Cell Biology of Lipids

ISSN: 1388-1981
5 Year impact factor: 4.3
Impact factor: 3.9

BBA Molecular and Cell Biology of Lipids publishes papers on original research dealing with novel aspects of lipid biology including the biosynthesis, degradation, and transport of lipids, the role of lipids and the lipidome in cells and whole organisms, and the regulation of lipid metabolism and function in normative health and disease states.Manuscripts should significantly advance the understanding of the molecular mechanisms underlying biological processes in which lipids are involved using biochemical, biophysical, cell and molecular biological, genetic, or physiological approaches. Papers detailing novel methodology should also include biochemical, molecular, or functional insight in the area of lipids. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Diabetes Epidemiology and Management

ISSN: 2666-9706
5 Year impact factor: 1
Impact factor: 1

Spin off title published in association with Diabetes & MetabolismDiabetes Epidemiology & Management is a peer-reviewed gold open-access e-only publication. The journal welcomes original articles, reviews and meta-analyses, pilot studies, reports that assess drug and medical device safety and tolerability in all phases of development. The Editors will especially encourage the publication of real-world data and papers on digital technologies, medical devices for diabetes using the data driven approach based on artificial intelligence, leading to remote monitoring and thus be able to cover new grounds with the journal. New formulations and changes in practice guidelines and standards are also welcome for publication. Viewpoints, editorials and research letters will complete the editorial offer.

Diabetes Research and Clinical Practice

ISSN: 0168-8227
5 Year impact factor: 5.9
Impact factor: 6.1

Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas.The role Diabetes Research and Clinical Practice is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care.The journal publishes topics including:translational sciencegeneticsimmunologynutritionpsychosocial researchepidemiologypreventionsocio-economic researchcomplicationsnew treatmentstechnologiestherapyDiabetes Research and Clinical Practice is the official journal of the International Diabetes Federation.

Endocrine Practice

ISSN: 1530-891X
5 Year impact factor: 3.6
Impact factor: 3.7

Endocrine Practice, the flagship journal of the American Association of Clinical Endocrinology, is a double-blind, peer-reviewed journal publishing the latest clinical information on the treatment of diabetes, nutrition and obesity, thyroid disease, bone and parathyroid disease, lipid and cardiovascular health, and pituitary, gonad, adrenal, and neuroendocrine disorders.The journal is intended to enhance the clinical knowledge, treatment, and management of pediatric and adult endocrine diseases for the endocrinologist and endocrine care community, and publishes original research, clinical trials, reviews, commentaries, and editorials. Special articles include AACE's clinical guidance documents: clinical practice guidelines, consensus statements, and treatment algorithms.

Endocrinología, Diabetes y Nutrición (English Edition)

ISSN: 2530-0180
5 Year impact factor: 1.7
Impact factor: 1.8

Endocrinología, Diabetes y Nutrición is the official journal of the Spanish Society of Endocrinology and Nutrition (Sociedad Española de Endocrinología y Nutrición, SEEN) and the Spanish Society of Diabetes (Sociedad Española de Diabetes, SED), and was founded in 1954. The aim of the journal is to improve knowledge and be a useful tool in practice for clinical and laboratory specialists, trainee physicians, researchers, and nurses interested in endocrinology, diabetes, nutrition and related disciplines. It is an international journal published in Spanish (print and online) and English (online), covering different fields of endocrinology and metabolism, including diabetes, obesity, and nutrition disorders, as well as the most relevant research produced mainly in Spanish language territories. The quality of the contents is ensured by a prestigious national and international board, and by a selected panel of specialists involved in a rigorous peer review. The result is that only manuscripts containing high quality research and with utmost interest for clinicians and professionals related in the field are published. The Journal publishes Original clinical and research articles, Reviews, Special articles, Clinical Guidelines, Position Statements from both societies and Letters to the editor. Endocrinología, Diabetes y Nutrición can be found at Science Citation Index Expanded, Medline/PubMed and SCOPUS.

FEBS Letters

ISSN: 0014-5793

FEBS Letters is one of the world's leading journals in biochemistry and is renowned both for its quality of content and speed of production. Bringing together the most important developments in the molecular biosciences, FEBS Letters provides an international forum for Minireviews, hypotheses and research letters that merit urgent publication.FEBS Letters offers: • Faster publication: − Accepted articles are published online in 3 days − The print version of the article is published in 3 to 5 weeks after acceptance • Full-text article disclosure in HTML and PDF formats • Articles in Press are included in PubMed • Easy online manuscript submission system • Transparent online peer review and manuscript tracking system • No page charges • Free color figuresSubject Coverage: The subject area of FEBS Letters is broad. It covers biochemistry (including protein chemistry, enzymology, nucleic acid chemistry, metabolism, and immunochemistry), structural biology, biophysics, computational biology (genomics, proteomics, bioinformatics), molecular genetics, molecular biology and molecular cell biology (signal transduction, intracellular traffic, regulation of cellular proliferation, cell-cell interactions) and systems biology. Studies on microbes, plants and animals at the molecular level are within the scope of FEBS Letters.Submitting Authors: Manuscripts can be submitted to FEBS Letters at: http://ees.elsevier.com/febsletters/

Journal of Clinical and Translational Endocrinology: Case Reports

ISSN: 2214-6245

Journal of Clinical and Translational Endocrinology: Case Reports is a companion title to the Journal of Clinical and Translational Endocrinology . It publishes case reports in a variety of disciplines in endocrinology, including diabetes, metabolic bone disease and osteoporosis, thyroid disease, pituitary and lipid disorders. Journal of Clinical & Translational Endocrinology Case Reports is an open access publication.

Journal of Diabetes and its Complications

ISSN: 1056-8727
5 Year impact factor: 2.9
Impact factor: 2.9

Journal of Diabetes and Its Complications (JDC) is a journal for health care practitioners and researchers. JDC aims to act as a source of information usable by diabetes practitioners and researchers to increase their knowledge about mechanisms of diabetes and complications development. Journal of Diabetes and Its Complications also aims to promote better management of people with diabetes who are at risk for those complications. JDC publishes original research about the pathogenesis, diagnosis and management of diabetes mellitus and its complications as well as articles on physiological and molecular aspects of glucose homeostasis.Manuscripts submitted to JDC can report any aspect of basic, translational or clinical research as well as epidemiology.Topics can range broadly from early prediabetes to late-stage complicated diabetes.The journal publishes topics relevant to basic/translational reports including:pancreatic islet dysfunction and insulin resistancealtered adipose tissue function in diabetesaltered neuronal control of glucose homeostasismechanisms of drug actionAnd also topics relevant to diabetic complications including:diabetic retinopathyneuropathynephropathyperipheral vascular diseasecoronary heart diseasegastrointestinal disordersrenal failureimpotencehypertensionhyperlipidemia

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health